In Vitro and Ex Vivo Effect of Hyaluronic Acid on Erythrocyte Flow Properties

Overview

Journal J Biomed Sci

Publisher Biomed Central

Specialty Biology

Date 2010 Feb 16

PMID 20152040

Citations 6

Authors

A Luquita

L Urli

M J Svetaz

A M Gennaro

M E Giorgetti

G Pistone

R Volpintesta

S Palatnik

M Rasia

Affiliations

Soon will be listed here.

Abstract

Background: Hyaluronic acid (HA) is present in many tissues; its presence in serum may be related to certain inflammatory conditions, tissue damage, sepsis, liver malfunction and some malignancies. In the present work, our goal was to investigate the significance of hyaluronic acid effect on erythrocyte flow properties. Therefore we performed in vitro experiments incubating red blood cells (RBCs) with several HA concentrations. Afterwards, in order to corroborate the pathophysiological significance of the results obtained, we replicated the in vitro experiment with ex vivo RBCs from diagnosed rheumatoid arthritis (RA) patients, a serum HA-increasing pathology.

Methods: Erythrocyte deformability (by filtration through nucleopore membranes) and erythrocyte aggregability (EA) were tested on blood from healthy donors additioned with purified HA. EA was measured by transmitted light and analyzed with a mathematical model yielding two parameters, the aggregation rate and the size of the aggregates. Conformational changes of cytoskeleton proteins were estimated by electron paramagnetic resonance spectroscopy (EPR).

Results: In vitro, erythrocytes treated with HA showed increased rigidity index (RI) and reduced aggregability, situation strongly related to the rigidization of the membrane cytoskeleton triggered by HA, as shown by EPR results. Also, a significant correlation (r: 0.77, p < 0.00001) was found between RI and serum HA in RA patients.

Conclusions: Our results lead us to postulate the hypothesis that HA interacts with the erythrocyte surface leading to modifications in erythrocyte rheological and flow properties, both ex vivo and in vitro.

Citing Articles

Hyaluronic acid impacts hematological endpoints and spleen histological features in African catfish (Clarias gariepinus).

Hamed M, Kotob M, Abou Khalil N, Anwari E, Bayoumie El Gazzar W, Idriss S BMC Vet Res. 2024; 20(1):294.

PMID: 38970005 PMC: 11225171. DOI: 10.1186/s12917-024-04113-9.

Anti-Inflammatory Effects of the 35kDa Hyaluronic Acid Fragment (B-HA/HA35).

Jia X, Shi M, Wang Q, Hui J, Shofaro J, Erkhembayar R J Inflamm Res. 2023; 16:209-224.

PMID: 36686276 PMC: 9846287. DOI: 10.2147/JIR.S393495.

Erythrocyte rheological properties but not whole blood and plasma viscosity are associated with severity of hypertension in older people.

Fu G, Ji M, Han L, Xu C, Pan F, Hu T Z Gerontol Geriatr. 2016; 50(3):233-238.

PMID: 27115524 DOI: 10.1007/s00391-016-1039-8.

Deficiency in mouse hyaluronidase 2: a new mechanism of chronic thrombotic microangiopathy.

Onclinx C, Dogne S, Jadin L, Andris F, Grandfils C, Jouret F Haematologica. 2015; 100(8):1023-30.

PMID: 25934767 PMC: 5004417. DOI: 10.3324/haematol.2015.123828.

Microcirculation.

Piagnerelli M, Ince C, Dubin A Crit Care Res Pract. 2012; 2012:867176.

PMID: 23091711 PMC: 3471451. DOI: 10.1155/2012/867176.

References

Horii K, Kubo S, Hirohashi K, Kinoshita H . Changes in erythrocyte deformability after liver resection for hepatocellular carcinoma associated with chronic liver disease. World J Surg. 1998; 23(1):85-90. DOI: 10.1007/s002689900570. View

Turan Y, Bal S, Gurgan A, Topac H, Koseoglu M . Serum hyaluronan levels in patients with knee osteoarthritis. Clin Rheumatol. 2007; 26(8):1293-8. DOI: 10.1007/s10067-006-0499-4. View

Harrison B, Symmons D, Barrett E, Silman A . The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. American Rheumatism Association. J Rheumatol. 1998; 25(12):2324-30. View

Cassera M, Silber A, Gennaro A . Differential effects of cholesterol on acyl chain order in erythrocyte membranes as a function of depth from the surface. An electron paramagnetic resonance (EPR) spin label study. Biophys Chem. 2002; 99(2):117-27. DOI: 10.1016/s0301-4622(02)00139-4. View

Wilkinson C, Bower L, Warren C . The relationship between hyaluronidase activity and hyaluronic acid concentration in sera from normal controls and from patients with disseminated neoplasm. Clin Chim Acta. 1996; 256(2):165-73. DOI: 10.1016/s0009-8981(96)06421-2. View

Luquita A, Urli L, Dominighini A, Svetaz M, Gennaro A, Volpintesta R . Haemorheological variables as a rheumatoid arthritis activity indicator. Clin Hemorheol Microcirc. 2004; 30(1):9-16. View

Majeed M, McQueen F, Yeoman S, McLean L . Relationship between serum hyaluronic acid level and disease activity in early rheumatoid arthritis. Ann Rheum Dis. 2004; 63(9):1166-8. PMC: 1755107. DOI: 10.1136/ard.2003.010942. View

Ninomiya T, Yoon S, Hayashi Y, Sugano M, Kumon Y, Seo Y . Clinical significance of serum hyaluronic acid as a fibrosis marker in chronic hepatitis C patients treated with interferon-alpha: histological evaluation by a modified histological activity index scoring system. J Gastroenterol Hepatol. 1998; 13(1):68-74. DOI: 10.1111/j.1440-1746.1998.tb00548.x. View

Cooper E, FORBES M . Serum hyaluronic acid levels in cancer. Br J Cancer. 1988; 58(5):668-9. PMC: 2246812. DOI: 10.1038/bjc.1988.283. View

10.

Goldberg R . Enzyme-linked immunosorbent assay for hyaluronate using cartilage proteoglycan and an antibody to keratan sulfate. Anal Biochem. 1988; 174(2):448-58. DOI: 10.1016/0003-2697(88)90043-7. View

11.

Rosenthal M, Gibbs P, Brown T, Wong S, Uren S, Ellis A . Phase I and pharmacokinetic evaluation of intravenous hyaluronic acid in combination with doxorubicin or 5-fluorouracil. Chemotherapy. 2005; 51(2-3):132-41. DOI: 10.1159/000085621. View

12.

Kovacs I, Sowemimo-Coker S, Kirby J, Turner P . Altered behaviour of erythrocytes in scleroderma. Clin Sci (Lond). 1983; 65(5):515-9. DOI: 10.1042/cs0650515. View

13.

Reid H, BARNES A, Lock P, Dormandy J, Dormandy T . A simple method for measuring erythrocyte deformability. J Clin Pathol. 1976; 29(9):855-8. PMC: 476193. DOI: 10.1136/jcp.29.9.855. View

14.

Luquita A, Urli L, Svetaz M, Gennaro A, Volpintesta R, Palatnik S . Erythrocyte aggregation in rheumatoid arthritis: Cell and plasma factor's role. Clin Hemorheol Microcirc. 2009; 41(1):49-56. DOI: 10.3233/CH-2009-1154. View

15.

Engstrom-Laurent A, Hallgren R . Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis. 1985; 44(2):83-8. PMC: 1001578. DOI: 10.1136/ard.44.2.83. View

16.

Luquita A, Gennaro A, Rasia M . Influence of adsorbed plasma proteins on erythrocyte rheological properties: in vitro and ex vivo studies. Pflugers Arch. 2001; 443(1):78-83. DOI: 10.1007/s004240100661. View

17.

Greiling H, HERBERTZ T, STUHLSATZ H . [CHROMATOGRAPHIC STUDIES ON THE MUCOPOLYSACCHARIDE DISTRIBUTION IN HYALINE CARTILAGE]. Hoppe Seylers Z Physiol Chem. 1964; 336:149-62. DOI: 10.1515/bchm2.1964.336.1.149. View

18.

Tomita M, Gotoh F, Tanahashi N, Turcani P . Whole-blood red blood cell aggregometer for human and feline blood. Am J Physiol. 1986; 251(6 Pt 2):H1205-10. DOI: 10.1152/ajpheart.1986.251.6.H1205. View

19.

Pons-Guiraud A . [Classification of the fillers available in France]. Ann Dermatol Venereol. 2008; 135(1 Pt 2):1S27-34. DOI: 10.1016/S0151-9638(08)70208-4. View

20.

Bertoluzzo S, Bollini A, Rasia M, Raynal A . Kinetic model for erythrocyte aggregation. Blood Cells Mol Dis. 2000; 25(5-6):339-49. DOI: 10.1006/bcmd.1999.0261. View